ExoVasc® PEARS

Exstent receives EU MDR Conformity Assessment Certfication

Following a successful audit in September 2023, Exstent has received its certificate certifying that is Quality Management System complies with the requirements of the EU-MDR for custom-made Class III Implantable devices. You can view the certificate here.

Three PEARS surgeons to present at TPC 2024, Sydney

Tal Golesworthy to present at BIOMAT & Mat SAN congress 2024

Interested in our patient experiences?

We develop medical devices that manage aortic dilation and minimise the risk of aortic dissection.

quick links

statements & policies

Our contact details

The staff of Exstent Limited are not medically qualified and are thus not able to provide clinical advice or answer questions of a clinical nature. We may direct your attention to publications in peer-reviewed journals that provide clinical information or provide information based upon personal experience. However, for any questions of a clinical nature patients are recommended to consult a qualified clinician.